Sericulture samples from CA
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA936929 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR23625912_1.fastq.gz | Fastqsanger.gz | |||
| SRR23625912_2.fastq.gz | Fastqsanger.gz | |||
| SRR23625913_1.fastq.gz | Fastqsanger.gz | |||
| SRR23625913_2.fastq.gz | Fastqsanger.gz | |||
| SRR23625914_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 6 |
Similar Datasets
Project description:Sericulture samples from control group Genome sequencing and assembly
| PRJNA955939 | ENA
Project description:Azotobacter vinelandii CA strain:CA Genome sequencing
| PRJNA186698 | ENA
Project description:We characterized the marine natural product cortistatin A (CA) as an inhibitor of CDK8 to determine whether pharmacologic inhibition of CDK8 regulates super-enhancer function and inhibits AML proliferation. In this series, we use ChIP-seq of H3K27ac, H3K4me1, MED1, CDK8, BRD4, and RNA polymerase II (PolII) to examine enhancer occupancy and transcriptional response to CA in human cells lines.
2015-09-25 | GSE65138 | GEO
Project description:Carcinoma-associated mesenchymal stem cells (CA-MSCs) are critical stromal progenitor cells within the tumor microenvironment. We previously demonstrated that CA-MSCs differentially express BMP genes, promote tumor cell growth, increase cancer ‘stemness’ and chemotherapy resistance. Here we use RNA sequencing of normal omental MSCs and ovarian CA-MSCs to demonstrate CA-MSCs have global changes in gene expression. Using these expression profiles we create a unique predictive algorithm to classify CA-MSCs. Our classifier, accurately distinguishes normal omental, ovary and bone marrow MSCs from ovarian cancer CA-MSCs. Suggesting broad applicability, the model correctly classifies pancreatic and endometrial cancer CA-MSCs and distinguishes cancer associated fibroblasts (CAFs) from CA-MSCs. Using this classifier, we definitively demonstrate ovarian CA-MSCs arise from tumor mediated reprograming of local tissue MSCs. While cancer cells alone cannot induce a CA-MSC phenotype, the in vivo ovarian tumor micoenvironment (TME) can reprogram omental or ovary MSCs to protumorigenic CA-MSC (classifier score of >0.96). In vitro studies suggest that both tumor secreted factors and hypoxia are critical to induce the CA-MSC phenotype. Interestingly, while the breast cancer TME can reprogram BM MSCs into CA-MSCs, the ovarian TME cannot, demonstrating for the first time that tumor mediated CA-MSC conversion is tissue and cancer type dependent. Together these findings (1) provide a critical tool to define CA-MSCs and (2) highlight cancer cell influence on distinct normal tissues providing powerful insights into the mechanisms underlying cancer specific metastatic niche formation. Carcinoma-associated mesenchymal stem cells (CA-MSCs) are critical stromal progenitor cells within the tumor microenvironment. We previously demonstrated that CA-MSCs differentially express BMP genes, promote tumor cell growth, increase cancer ‘stemness’ and chemotherapy resistance. Here we use RNA sequencing of normal omental MSCs and ovarian CA-MSCs to demonstrate CA-MSCs have global changes in gene expression. Using these expression profiles we create a unique predictive algorithm to classify CA-MSCs. Our classifier, accurately distinguishes normal omental, ovary and bone marrow MSCs from ovarian cancer CA-MSCs. Suggesting broad applicability, the model correctly classifies pancreatic and endometrial cancer CA-MSCs and distinguishes cancer associated fibroblasts (CAFs) from CA-MSCs. Using this classifier, we definitively demonstrate ovarian CA-MSCs arise from tumor mediated reprograming of local tissue MSCs. While cancer cells alone cannot induce a CA-MSC phenotype, the in vivo ovarian tumor micoenvironment (TME) can reprogram omental or ovary MSCs to protumorigenic CA-MSC (classifier score of >0.96). In vitro studies suggest that both tumor secreted factors and hypoxia are critical to induce the CA-MSC phenotype. Interestingly, while the breast cancer TME can reprogram BM MSCs into CA-MSCs, the ovarian TME cannot, demonstrating for the first time that tumor mediated CA-MSC conversion is tissue and cancer type dependent. Together these findings (1) provide a critical tool to define CA-MSCs and (2) highlight cancer cell influence on distinct normal tissues providing powerful insights into the mechanisms underlying cancer specific metastatic niche formation.
2018-08-17 | GSE118624 | GEO
Project description:The Rett syndrome protein MeCP2 was described as a methyl-CpG-binding protein, but its exact function remains unknown. Here we show that MeCP2 is a microsatellite binding protein that specifically recognizes hydroxymethylated CA repeats. Depletion of MeCP2 alters chromatin organization of CA repeats and lamina-associated domains and results in nucleosome accumulation on CA repeats and genome-wide transcriptional dysregulation. The structure of MeCP2 in complex with a hydroxymethylated CA repeat reveals a characteristic DNA shape, with significantly modified geometry at the 5-hydroxymethylcytosine, which is recognized specifically by Arg133, a key residue whose mutation causes Rett syndrome. Our work identifies MeCP2 as a microsatellite DNA binding protein that targets the 5hmC-modified CA-rich strand and maintains genome regions nucleosome-free, suggesting a role for MeCP2 dysfunction in Rett syndrome.
2021-06-25 | GSE124240 | GEO
Project description:The Rett syndrome protein MeCP2 was described as a methyl-CpG-binding protein, but its exact function remains unknown. Here we show that MeCP2 is a microsatellite binding protein that specifically recognizes hydroxymethylated CA repeats. Depletion of MeCP2 alters chromatin organization of CA repeats and lamina-associated domains and results in nucleosome accumulation on CA repeats and genome-wide transcriptional dysregulation. The structure of MeCP2 in complex with a hydroxymethylated CA repeat reveals a characteristic DNA shape, with significantly modified geometry at the 5-hydroxymethylcytosine, which is recognized specifically by Arg133, a key residue whose mutation causes Rett syndrome. Our work identifies MeCP2 as a microsatellite DNA binding protein that targets the 5hmC-modified CA-rich strand and maintains genome regions nucleosome-free, suggesting a role for MeCP2 dysfunction in Rett syndrome.
2021-06-25 | GSE154111 | GEO
Project description:Citrobacter braakii strain CA-26 assembly
| PRJNA361481 | ENA
Project description:“Bathymodiolus” childressi is a species of deep-sea mussels found predominantly in the Gulf of Mexico harbouring a methane oxidizing symbiont (MOX). Ca. Endonucleobacter is a gammaproteobacterial intranuclear parasite that infects the ciliated edge cells of the deep-sea mussel “B.” childressi. After a single Ca. Endonucleobacter cell invades the host nucleus, it proliferates massively, increasing the volume of the nucleus up to 50 fold. It is hypothesized that intranuclear parasites use host chromatin as a nutritional source, however, this would lead to a destabilization of the replication niche. The aim of this study was to investigate how Ca. Endonucleobacter thrives in the nucleus and how it affects the host cell using various “-omics' ' approaches. In addition to protein identification we generated a high quality genome draft for Ca. Endonucleobacter using a hybrid assembly pipeline (PacBio + Illumina reads). We annotated this high quality genome draft and used it as a reference to identify the proteins responsible for the molecular interaction between Ca. Endonucleobacter and its host cell. The 12 specimens of “B.” childressi analyzed in this study were collected during five dives from the Mississippi Canyon site (MC853, 28º07’ N; -089º08’ W) and the Green Canyon site (GC234, 27º45’ N; -091º13’ W) at a water depth of 1,070 and 540 m, respectively. The mussels were selected according to their degree of Ca. Endonucleobacter infection. According to this criterion, the “B.” childressi specimens were divided into two conditions: 8 were classified as “infected”, while 4 were classified as “non-infected” (negative control). For each specimen, we prepare microdissected ciliated edge samples in triplicates.
2025-01-13 | PXD020317 | Pride
Project description:Metagenomic samples from composting
| PRJNA1083291 | ENA
Project description:Healthy danish metagenomic samples
| PRJEB41786 | ENA